NCT03111212View on ClinicalTrials.gov

Iloprost in Acute Respiratory Distress Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

May 14, 2021

Study Completion Date

August 14, 2021

Conditions
Respiratory Distress Syndrome, Adult
Interventions
DRUG

Iloprost

Iloprost nebulized

DRUG

control

sodium chloride 0,9% nebulized

Trial Locations (1)

72076

University Hospital Tuebingen, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT03111212 - Iloprost in Acute Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter